• H.R. 4710, 340B PAUSE Act, establishing a moratorium on the registration of new 340B hospitals and associated sites, and requiring reporting of program data. H.R. 1892, Bipartisan Budget Act of 2018, provisions relating to manufacturers share of cost-sharing for Medicare beneficiaries in the donut hole phase of Part D plan coverage.
• H.R. 6, legislation to address opioids manufacturing and distribution Pandemic and All-Hazards Preparedness Reauthorization Act (PAHPRA), vaccines and other various provisions.

Duration: March 29, 2018 to December 31, 2018

General Issues: Medicare/Medicaid, Health Issues

Spending: about $170,000 (But it's complicated. Here's why.)

It can be tricky to figure out how much an organization spent on a particular lobbying engagement. The law only requires lobbyists to report the amount they were paid for federal lobbying each quarter rounded to the nearest $10,000—and if it's less than $3,000 in a given quarter (or less than $13,000 for organizations with in-house lobbyists), they don't have to disclose it at all. Plus, some organizations include spending that doesn’t belong in the report—for instance, money spent lobbying state governments or other legal work.

Agencies lobbied since 2018: U.S. Senate, House of Representatives

Related Foreign Entities: Horizon Pharma PLC (Dublin, IRL); contribution to lobbying: $0; ownership 100%